Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites.
Craparotta I, Mannarino L, Zadro R, Ballabio S, Marchini S, Pavesi G, Russo M, Renne SL, Meroni M, Ponzo M, Bello E, Sanfilippo R, Casali PG, D'Incalci M, Frapolli R.
Craparotta I, et al. Among authors: meroni m.
J Exp Clin Cancer Res. 2024 Nov 26;43(1):309. doi: 10.1186/s13046-024-03228-z.
J Exp Clin Cancer Res. 2024.
PMID: 39587691
Free PMC article.